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Background: Mesenchymal–epithelial transition (MET) is now suggested to participate in the process of metastatic
tumor formation. However, in hepatocellular carcinoma (HCC) the process is still not well revealed.
Methods: Paraffin-embedded tissue samples were obtained from 13 patients with HCC in Shengjing Hospital of
China Medical University. The expression of E-cadherin, Fibronectin, N-cadherin, Vimentin, Hepatocyte nuclear factor
4alpha (HNF4alpha), Snail and Slug was assessed in primary tumors and their corresponding metastases by
immunohistochemical staining. Next, the expression of HNF4alpha and E-cadherin in four HCC cell lines was
examined. Furthermore, SK-Hep-1 cells were transfected with human HNF4alpha expression vector, and the change
of E-cadherin expression was assessed.
Results: 45.2% (14/31) of the lesions in the metastases showed increased E-cadherin expression compared with the
primaries, suggesting the possible occurrence of MET in metastatic tumor formation of HCC, as re-expression of
E-cadherin is proposed to be the important hallmark of MET. The occurrence of MET was also confirmed by the
reduced expression of Fibronectin (54.8%, 17/31), N-cadherin (38.7%, 12/31) and Vimentin (61.3%, 19/31) in the
metastases. 45.2% (14/31) of the lesions in the metastases also showed increased HNF4alpha expression, and 67.7%
(21/31) and 48.4% (15/31) of metastases showed decreased Snail and Slug expression respectively. Statistical results
showed that the expression of HNF4alpha was positively related with that of E-cadherin, and negatively correlated
with that of Snail, Slug and Fibronectin, suggesting that the expression change of the MET markers in the
metastatic lesions might be associated with HNF4alpha. Among the four HCC cell lines, both HNF4alpha and
E-cadherin expressed high in Hep3B and Huh-7 cells, but low in SK-Hep-1 and Bel-7402 cells. Furthermore, the
expression of E-cadherin increased accordingly when SK-Hep-1 cells were transfected with human HNF4alpha
expression vector, further confirming the role of HNF4alpha in the regulation of E-cadherin expression.
Conclusions: Our clinical observations and experimental data indicate that HNF4alpha might play a crucial role in
the metastatic tumor formation of HCC, and the mechanism may be related with the process of phenotype
transition.
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Hepatocellular carcinoma (HCC) is one of the most com-
mon cancers worldwide, and the mortality rate is rather
high [1]. Nowadays, surgical resection or liver transplan-
tation remains the main and effective treatment through-
out the world [2]. However, though great improvements
have been made in the field of operative surgery, the long-
term survival remains unsatisfied, mainly due to posto-
perative recurrence or metastasis [3]. Hence, investigation
of the molecular mechanism of metastasis and recurrence
would provide for the improvements of prognosis for the
patients with HCC.
Recently, it has been demonstrated that mesenchymal–
epithelial transition (MET) plays an important role in the
metastasis of several kinds of tumors [4], while the experi-
mental data supporting the role of MET in HCC are still
limited. In 1996, Osada T proved that epithelial phenotype
and E-cadherin played an important role in the process of
intrahepatic metastasis of HCC, via two HCC cell sublines
with different metastatic abilities, Li7HM and Li7NM [5].
However, further research was not carried out. In addition,
Asayama Y performed an immunohistochemical study on
8 cases of HCC and its intrahepatic metastases, and found
that the expression of E-cadherin and beta-catenin of
intrahepatic metastases was similar to or even higher than
those of primary lesions, suggesting that E-cadherin and
beta-catenin might be significantly correlated with the
metastatic tumor formation of HCC [6]. As the re-
expression of E-cadherin is proposed to be the important
hallmark of MET [7], it could be speculated that the MET
might also play an important role in metastatic tumor
formation of HCC.
The hepatocyte nuclear factor 4alpha (HNF4alpha) is a
member of the steroid hormone receptor family, and plays
an important role in regulation of hepatic gene expression
[8]. Recently, it was reported that HNF4alpha is essential
for morphological and functional differentiation of hepa-
tocytes [9]. The genome-scale chromatin immunopre-
cipitation assay showed that HNF4alpha could bind to the
promoters of nearly half of the genes that are expressed in
the mouse liver, including cell adhesion and junctional
proteins that allow the hepatic cells to form a polarized
epithelium [10], suggesting that HNF4alpha should be
a dominant regulator of the epithelial phenotype. In
addition, it was demonstrated that the expression of
HNF4alpha in dedifferentiated rat hepatoma H5 cells
could result in re-expression of cytokeratin proteins and
partial reestablishment of E-cadherin production [11].
Forced re-expression of HNF4alpha in a dedifferentiated
hepatoma cell line was also shown to induce the cells to
re-form junctions and express hepatocyte marker genes
[12]. So, it could be speculated that HNF4alpha may be
also a main regulator of E-cadherin expression in HCC, or
even an important participant in the metastatic tumorformation of HCC. Besides, recently HNF4alpha was
found to be able to directly inhibit transcription of the
EMT master regulatory genes Snail and Slug and of
several mesenchymal markers, and it might be just by this
mechanism that HNF4alpha could induce the MET [13].
Therefore, in this study we aimed to experimentally
examine whether HNF4alpha take part in the metastatic
tumor formation of HCC and its relationship with the
MET markers. An immunohistochemical study of the
expression of E-cadherin and some other markers of MET
(including Vimentin, Fibronectin and N-cadherin) re-
vealed the increased E-cadherin, and reduced Fibronectin,
N-cadherin and Vimentin expression in the metastases
compared with the primaries, suggesting that the MET
occurred. The expression of HNF4alpha was similarly
increased with that of E-cadherin in the metastases, and
the expression of Snail and Slug in the metastases was
significantly reduced compared with the primaries. In
addition, it was showed that the expression of HNF4alpha
was positively related with that of E-cadherin, but
negatively related with the expression of Fibronectin, Snail
and Slug in primary tumors and metastatic lesions of
HCC. These suggested that HNF4alpha might also play a
crucial role in the metastatic tumor formation of HCC,
and might possibly be related with the expression change
of E-cadherin, Fibronectin, Snail and Slug. Furthermore,
the examination of HNF4alpha and E-cadherin expression
in four HCC cell lines revealed again the association of
E-cadherin expression with the HNF4alpha expression,
and it was found that increased expression of HNF4alpha
in SK-Hep-1 cells could result in an increased expression
of E-cadherin, confirming the role of HNF4alpha in the
regulation of E-cadherin expression. What we found sug-
gested that HNF4alpha might play an important role in
the metastatic tumor formation of HCC, and it might be
related with the expression change of MET markers, or
even the MET in the metastases.
Methods
Cell culture
American Type Culture Collection (ATCC) cell lines,
Hep3B and SK-Hep-1 cells were cultured in MEM
medium with 10% fetal bovine serum. Bel-7402 cells
were cultured in RPMI-1640 medium with 10% fetal
bovine serum, while Huh-7 cells were cultured in DMEM
medium with 10% fetal bovine serum. All cells were incu-
bated at 37°C in 5% CO2.
Immunohistochemistry
Paraffin-embedded patient samples were obtained from
Shengjing Hospital of China Medical University. In-
formed consent was obtained directly from individual
patients and subject’s relatives, and the experimental
protocols were reviewed and approved by the Ethics
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The staining procedures were performed according to the
manufacturer’s protocols. Immunostaining was performed
on 4 μm paraffin-embedded tissue sections. The slides
were deparaffinized in xylene and dehydrated in a graded
ethanol series, and the sections underwent antigen re-
trieval in citrate solution. Endogenous peroxidase was
blocked with 3% hydrogen peroxide, and the sections were
washed with phosphate-buffered saline. After blocking,
they were incubated overnight with E-cadherin (1:200,
sc-8426, Santa Cruz Biotechnology, Santa Cruz, CA),
Vimentin (1:100, Santa Cruz Biotechnology, Santa Cruz,
CA), Fibronectin(1:100, sc-18825, Santa Cruz Biotech-
nology, Santa Cruz, CA), N-cadherin (1:100, Santa Cruz
Biotechnology, Santa Cruz, CA), HNF4alpha (1:150,
BS2983, Bioworld Technology), Snail (1:50, ab135708,
Abcam Technology) or Slug (1:100, #9585, Cell Signaling
Technology) primary antibodies. Antigen staining was
performed using DAB horseradish peroxidase color deve-
lopment kit and then counterstained with hematoxylin.
The immunoreactivity of proteins in each tissue core was
assessed independently by two experienced pathologists
for staining intensity (0 absent, 1 weak, 2 intermediate, 3
strong staining).Western blot
Cell lysate proteins were resolved on 8% sodium dodecyl
sulfate polyacrylamide gel electropheresis (SDS-PAGE)
and transferred to PVDF membranes. After blocking,
membranes were incubated with primary antibodies
against E-cadherin (1:250, sc-8426, Santa Cruz Biotechno-
logy, Santa Cruz, CA), HNF4alpha (1:250, sc-8987, Santa
Cruz Biotechnology, Santa Cruz, CA) and β-actin (1:200,
sc-69879, Santa Cruz Biotechnology, Santa Cruz, CA),
followed by incubation with peroxidase-conjugated secon-
dary antibodies and chemiluminescence detection.Immunofluorescence analysis
2×104 Hep3B or SK-Hep-1 cells on cover glass were
washed and fixed with 4% paraformaldehyde at 4°C for
2 h. The cells were treated with 0.1% Triton X-100 for
15 min at room temperature and were blocked for
30 min with blocking buffer (10% BSA in PBS) at room
temperature. The cells were incubated for overnight with
E-cadherin (1:50, sc-7870, Santa Cruz Biotechnology,
Santa Cruz, CA), HNF4alpha (1:150, sc-8987, Santa Cruz
Biotechnology, Santa Cruz, CA) and vimentin (1:100,
BS1855, Bioworld Technology) primary antibodies, fol-
lowed by incubation with the appropriate fluorophore-
labeled secondary antibody for 1 h, and then for 15 min
with 10 μM Heochst 33342 at room temperature. Visua-
lization was performed on an Olympus fluorescence
microscope.Transient transfection
Cells were seeded as 6×105 cells per well of 6-well plate.
After about 16 h, cells were transfected with 4 μg of
pTarget-HNF4alpha plasmids (a kind gift from Kobayashi
K [14]), and 10 μl of Lipofectamine2000 (Invitrogen, CA)
according to the manufacturer’s protocol. After 48 h
transfection, the cells were collected for detection.
Stable transfection
Cells were seeded as 2×105 cells per well of 24-well plate.
After 16 h, cells were transfected with 0.8 μg of pTarget-
HNF4alpha plasmids and 2 μl of Lipofectamine2000. After
24 h, the cells were cultured in 900 μg/ml G418 to select
for stable transfection. After about 2 weeks, the stable
clones were picked for growth on plates, and maintained
in 450 μg/ml G418 for the detection of ideal clones.
Statistical analysis
The Wilcoxon matched pairs test was used to test the dif-
ferences of E-cadherin, Fibronectin, N-cadherin, Vimentin,
HNF4alpha, Snail or Slug expression between primary liver
tumors and their corresponding metastases. Spearman
correlation analysis was used to test the correlation
of HNF4alpha with E-cadherin, Vimentin, Fibronectin,
N-cadherin, Snail and Slug expression in primary liver
tumors and their corresponding metastases. All p values
reported are two-sided, and the significance level was
set at less than 0.05. The analyses were performed with
the SPSS 13.0 statistical software program.
Results
The expression change of the MET markers in primary
HCC lesions and their corresponding metastases
A few studies have examined E-cadherin expression in
the primary tumor and distant metastases, including
breast or prostate cancer specimens, and the role of
E-cadherin in metastatic tumor formation has been
gradually revealed [15,16]. To conduct our survey focu-
sing on metastases of HCC, we obtained specimens of
primary tumors and the corresponding metastases from
13 patients with HCC. The metastatic sites from which
the lesions could be obtained included the lymph nodes
(24 lesions), stomach (4 lesions), and peritoneum (3 le-
sions). Both primary tumor and metastases were immu-
nostained for E-cadherin. E-cadherin positive cells were
counted based on high intensity membrane or cytoplas-
mic staining, as E-cadherin expression was not always
localized to the membrane [16].
Overall, the expression of E-cadherin in the primary
tumors showed weak in 10 cases, intermediate in the
other 3 cases, while the expression of E-cadherin in the
metastases showed absent in 2 lesions, weak in 11 le-
sions, intermediate in 12 lesions and strong in 6 lesions
(Figure 1A). It was found that 45.2% (14/31) of the
Figure 1 The expression of MET marks in primary tumors and their corresponding metastases suggested the occurrence of MET in the
metastases. A) The number of the lesions with different staining intensity of the MET marks (including E-cadherin, N-cadherin, Fibronectin and
Vimentin) in the primary tumors and their corresponding metastases. B) The expression change of MET marks in the metastases compared with
their corresponding primary tumors (increased E-cadherin, decreased N-cadherin, Fibronectin and Vimentin expression), marking via the lines,
showed the occurrence of MET in the metastases. C) The examples of the cases with increased E-cadherin, decreased N-cadherin, Fibronectin and
Vimentin expression in the metastases compared with their primary tumors were showed. In the normal tumor-adjacent tissue, the expression of
E-cadherin was mainly strong, but the expression of N-cadherin, Fibronectin and Vimentin was usually negative.
Yao et al. BMC Cancer 2013, 13:432 Page 4 of 11
http://www.biomedcentral.com/1471-2407/13/432lesions in the metastases showed increased E-cadherin
expression compared with the primaries, while only
12.9% (4/31) showed decreased E-cadherin expression
(Figure 1B). The expression of E-cadherin in metastases
was significantly increased (p<0.05 by Wilcoxon paired
analyses), suggesting that the E-cadherin might play an
important role in the formation of HCC metastases.
A closer examination of the specimens revealed stri-
king differences of E-cadherin expression between the
primary tumor and the metastases in some cases, with
the primary tumor wholly negative and the metastases
mostly positive for E-cadherin expression (Figure 1C).Interestingly, though the metastases mostly showed only
increased cytoplasmic expression of E-cadherin, in some
cases, the metastases also showed recovered membranous
expression of E-cadherin (Figure 1C).
E-cadherin is now recognized as an indicator of mesen-
chymal to epithelial reverting transitions during the meta-
static seeding of disseminated carcinomas [7]. In order to
further investigate the phenotype transitions during the
metastasis of HCC, we analyzed the expression pattern of
some more markers of MET, including Vimentin, Fibro-
nectin and N-cadherin. Immunostaining analysis revealed
that 38.7% (12/31) of metastases showed decreased N-
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showed decreased Fibronectin expression (Figure 1B),
61.3% (19/31) of metastases showed decreased Vimentin
expression (Figure 1B). Now, the significantly decreased
expression of N-cadherin, Fibronectin and Vimentin
(p<0.05 by Wilcoxon paired analyses) comfirmed the
occurrence of MET in the metastases.
In addition, among the 13 cases of primary tumors,
normal tumor-adjacent tissues could be found in 11
cases. It was found that comparing with these normal
tumor-adjacent tissues, the expression of E-cadherin in
the primary tumors was all down-regulated (Figure 1C),
and in the metastases most of E-cadherin expression
were also slightly reduced, though in some cases (19.4%,
6/31) the expression of E-cadherin in the metastases was
similar with that in the normal tissues (Figure 1C). For
the other markers, compared with these normal tumor-
adjacent tissues, most of the Fibronectin (76.9%, 10/13),
N-cadherin (69.2%, 9/13), and Vimentin (92.3%, 12/13)
expression in the primaries appeared increased, while
most of the metastases (48.4%, 15/31, 58.1%, 18/31,
48.4%, 15/31 respectively for Fibronectin, N-cadherin
and Vimentin) showed a low-expressed appearance,
similarly with the normal tissues (Figure 1C).
The expression of HNF4alpha increased in HCC
metastases and was closely related with the expression of
MET markers, Snail, and Slug
To reveal the regulatory mechanism of E-cadherin expres-
sion, both the primary tumors and metastases were also
immunostained for HNF4alpha, which might be a main
regulator of E-cadherin expression in HCC. HNF4alpha
immunoreactivity was similarly determined. Each tissue
core was assessed for nuclear or cytoplasmic staining
intensity (absent, weak, intermediate or strong), as the
expression position of HNF4alpha in tumor would also be
changed [17]. Overall, the expression of HNF4alpha in the
primary tumors showed absent in 1 case, weak in 10 cases
and intermediate in the other 2 cases, while expression of
HNF4alpha in the metastases showed absent in 5 lesions,
weak in 9 lesions, intermediate in 10 lesions and strong in
the other 7 lesions (Figure 2A). It was found that 45.2%
(14/31) of the lesions showed increased HNF4alpha
expression in the metastases compared with the primaries,
while only 12.9% (4/31) showed decreased HNF4alpha
expression in the metastases (Figure 2B). The difference of
HNF4alpha expression in primary tumors and their corre-
sponding metastatic lesions was also significant (p<0.05 by
Wilcoxon paired analyses).
Similarly, it could also be found that in some cases with
the primary tumor negative expression of HNF4alpha,
the metastases showed obvious HNF4alpha expression
(Figure 2C). In addition, comparing with the normal tissues,
the expression of HNF4alpha in either the primary tumorsor the metastases was mostly down-regulated (Figure 2C),
with only a small part of metastases (22.6%, 7/31) showing
a similar expression with the normal tissues.
In our study, the expression of two EMT master regula-
tory genes, Snail and Slug, whose transcription was intro-
duced to be able to be directly inhibited by HNF4alpha,
was also detected in the primary HCC tumor and corre-
sponding distant metastases. 67.7% (21/31) and 48.4% (15/
31) of cases showed decreased Snail and Slug expression
in the metastases compared with the primaries, while only
12.9% (4/31) and 16.1% (5/31) showed increased Snail and
Slug expression in the metastases (Figure 2B). The differ-
ence of Snail and Slug expression in primary tumors and
their corresponding metastatic lesions was also significant
(p<0.05 by Wilcoxon paired analyses). In addition, the
expression of Snail and Slug in normal tumor-adjacent
tissues was mostly weak or negative (Figure 2C).
The expression of HNF4alpha, Snail, Slug, E-cadherin,
Fibronectin, N-cadherin and Vimentin was all detected
in the primary tumors and their corresponding metasta-
ses. It was found that comparing with the normal tis-
sues, the expression of both HNF4alpha and E-cadherin
in primary tumors was mostly decreased, while the
expression of Snail, Slug, Fibronectin, N-cadherin and
Vimentin was mostly increased. Besides, both E-cadherin
and HNF4alpha mostly showed increased expression in
the metastases compared with the primary tumors, while
Snail, Slug, Fibronectin, N-cadherin and Vimentin mostly
showed decreased expression in the metastases. Spearman
correlation analysis showed that the expression of Snail
and Slug in the primary tumors and their corresponding
metastases was negatively correlated with the expression
of E-cadherin, and positively correlated with that of
Fibronectin, N-cadherin and Vimentin (Additional file 1:
Table S1), confirming again that Snail and Slug were the
EMT master regulatory genes. In addition, as previous
studies showed that HNF4alpha might induce the MET
through inhibiting the transcription of EMT master
regulatory genes Snail and Slug, it could be speculated
that the expression of Snail, Slug, E-cadherin, Fibronec-
tin, N-cadherin and Vimentin might be closely associated
with that of HNF4alpha. Spearman correlation analysis
showed that the expression of HNF4alpha in the primary
tumors and their corresponding metastases was sig-
nificantly positively correlated with the expression of
E-cadherin, and negatively correlated with the expression
of Snail, Slug and Fibronectin (Additional file 1: Table S1),
primarily demonstrating the conjecture.
The important role of HNF4alpha in the regulation of E-
cadherin expression in HCC cells
The results of immunohistochemistry detection on HCC
specimens showed that the expression of E-cadherin was
closely correlated with that of HNF4alpha. Next, four HCC
Figure 2 The expression of HNF4alpha, slug and snail in primary tumors and their corresponding metastases. A) The number of the
lesions with different staining intensity of HNF4alpha, Slug and Snail in the primary tumors and its metastases. B) The expression change of
HNF4alpha, Slug and Snail in the metastases compared with their corresponding primary tumors, marking via the lines, showed the role of
HNF4alpha, Slug and Snail in the metastases. C) The examples of the cases with increased HNF4alpha, decreased Slug and Snail expression in the
metastases compared with their primary tumors were showed. In the normal tumor-adjacent tissue, the expression of HNF4alpha was mainly
strong, while the expression of Slug and Snail was usually negative.
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E-cadherin and HNF4alpha via western blot examination. It
was showed that E-cadherin and HNF4alpha protein
expression were both strong in Hep3B and Huh-7 cells, but
weak in SK-hep-1 and BEL-7402 cells (Figure 3). These
showed again the possibly close correlation of the E-cadherinand HNF4alpha expression. Besides, immunofluorescence
examination in the SK-hep-1 and Hep3B cells confirmed the
result of western blot examination (Figure 4). Furthermore,
the expression of vimentin was also detected, and it was
found that the expression difference of the vimentin in the
two HCC cell lines was not obvious (Figure 4).
Figure 3 Correlation of the E-cadherin and HNF4alpha
expression showed in four HCC cell lines. The expression of
E-cadherin and HNF4alpha was detected in four HCC cell lines by
western blot examination. It was showed that E-cadherin and
HNF4alpha protein expression were both strong in Hep3B and
Huh-7 cells, but weak in SK-hep-1 and BEL-7402 cells, showing the
correlation of the E-cadherin and HNF4alpha expression.
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sion was undetected via western blot detection were
selected for the transfection, to reveal the role of
HNF4alpha in the regulation of E-cadherin expression.
The SK-Hep-1 cells were transfected with HNF4alpha-
expression plasmid. The expression of HNF4alpha was
confirmed to increase, and the expression of E-cadherin
was revealed to increase correspondingly (Figure 5),
confirming that HNF4alpha play an important role in the
regulation of E-cadherin expression, in the human liver
cancer cells.
Discussion
Though much more progress has been got during the
researches for the metastasis of tumors, the mechanism
of tumor metastases formation, which is the later stage
of metastasis, is rarely revealed. One important reason
for this is that the clinical metastases specimens are
much more difficult to get. Nowadays, some researches
that were carried out for tumor metastases revealed that
many metastatic lesions and their corresponding primary
tumors shared a similar epithelial nature. Some metasta-
ses of a number of carcinomas, including prostatic can-
cer, breast carcinoma, colorectal cancer, ovarian cancer
and pulmonary cancer, were even less dedifferentiated
than their corresponding primary tumors [4]. As for
HCC, it was revealed in the Asayama Y’s study that the
expression of E-cadherin in intrahepatic metastases was
similar with those of primary lesions in most cases, while
in two cases with reduced E-cadherin expression in the
primary sites, the expression of E-cadherin in intra-
hepatic metastases was even preserved [6]. Based on the
observations of increased E-cadherin expression inmetastases compared with primary tumors, they proposed
that preserved or recovered E-cadherin expression might
be of beneficial effect, possibly for re-establishing the tis-
sue architecture at the metastatic site [6].
In our study, we surveyed a set of matched primary and
metastatic tumors, for the expression of E-cadherin in the
HCC specimens. It was found that 45.2% of metastases
expressed increased E-cadherin compared with the primary
tumors, which mostly exhibited low or negative E-cadherin
expression, suggesting again the possible role of E-cadherin
in the metastases formation of HCC. In addition, as the re-
expression of E-cadherin is proposed to be the important
hallmark of MET [7], it also suggested that the MET might
play an important role in metastatic tumor formation of
HCC. In our study, some other marks of MET, including
vimentin, fibronectin, N-cadherin, were also examined. It
was found that 38.7%, 54.8% and 61.3% of metastases
showed decreased expression of N-cadherin, Fibronectin
and Vimentin respectively. These results further suggested
the possible occurrence of MET in the metastases of HCC.
EMT represents a fundamentally important process that
is conducive to tumor dissemination [18,19]. EMT in
cancer progression and metastasis has been widely studied
through in vitro cell culture and in vivo animal models of
cancer progression [20]. The downregulation or silencing
of E-cadherin, which is the key molecule for the main-
tenance of epithelial integrity and polarized function, is
the critical event of EMT. It is thought in the EMT theory
that epithelial cells could acquire fibroblast-like properties
and exhibit reduced cell-cell adhesion and increased
motility via EMT [21]. Whereas, at present, the results of
tumor metastases examination showed that the metastases
did not only compose of mesenchymal tumor cells, and
this seemed to be in contradiction with the theory of
EMT. Now, it is proposed that the process of MET would
occur in later stages of tumor metastasis, possibly to fit
into the metastatic process, explaining why the distant
metastases had similar phenotype with the primary lesions
[22-24].
As for the possible mechanism that the MET contrib-
utes to the metastatic tumor formation, it was thought
that the re-expressed E-cadherin might contribute to the
formation of metastatic tumors by helping the establish-
ment of organizational structure in metastases [25]. What
is more, the E-cadherin was also found to be able to
activate intracellular proliferation and survival signals by
activating the survival-associated mitogen activated pro-
tein kinase (MAPK) and Akt/PKB cascades in the distance
microenvironment [26]. Certainly, the exact related
mechanism of the MET in the metastases is still waiting
for further revelation [4].
In this study, we also detected the expression of
HNF4alpha, which was found to possibly play an im-
portant role in the expression regulation of E-cadherin
Figure 4 The expression of HNF4alpha, E-cadherin and vimentin in SK-hep-1 and Hep3B cells. Immunofluorescence examination showed
again the expression of E-cadherin and HNF4alpha in Hep3B cells was stronger than that in SK-hep-1 cells. In addition, it was found that the
expression of vimentin in SK-hep-1 cells is similar with that in Hep3B cells.
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tases. It was revealed that 45.2% of HCC metastatic
lesions also expressed higher HNF4alpha than their cor-
responding primary foci, and the positive expression of
HNF4alpha and E-cadherin in HCC and its metastases was
obviously relevant, primarily suggesting that HNF4alpha
might also play a crucial role in the metastatic tumorformation of HCC, and might be related with the expres-
sion change of E-cadherin in primary hepatic tumors or its
metastases.
HNF4alpha has been previously recognized as a main
regulator of E-cadherin expression. It was found that
HNF4alpha could induce increased expression of E-
cadherin in two HCC cell lines with epithelial
Figure 5 HNF4alpha regulated the expression of E-cadherin in HCC cells. The SK-Hep-1 cells were transfected with HNF4alpha-expression
plasmid. As the expression of HNF4alpha increased, the expression of E-cadherin correspondingly increased. A) Transient transfection.
B) Stable transfection.
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could regulate the expression of E-cadherin in human
hepatoma cells [27]. Now, the role of HNF4alpha in the
expression regulation of E-cadherin in the HCC cells with
mesenchymal phenotypes was further confirmed in our
study via transfection, as it was found that the expression
of E-cadherin increased accordingly when SK-
Hep-1 cells were transfected with human HNF4alpha ex-
pression vector. Though in our study, it was found that
the transfected cells were not epithelialized (data not
showed), the role of HNF4alpha on the induction of MET
could not be easily denied. In the Späth GF’s study, it was
also found that HNF4 could only result in reexpression of
cytokeratin proteins and partial reestablishment of E-
cadherin production, and the cells were not epithelialized.
But they found that only the transfectants are competent
to respond to the synthetic glucocorticoid dexamethasone,
which induces the second step of morphogenesis, inclu-
ding formation of the junctional complex and expression
of a polarized cell phenotype, suggesting that HNF4
should be an important part of the MET inducers. In
addition, it was also introduced that the expression of
HNF4alpha could directly induce the MET in fibroblasts
(NIH3T3 cells) [9], and Utilizing rat hepatoma cell lines,
Natalia L Lazarevich et al also proved that dedifferentiated
hepatoma cells can be induced to transform to the epithe-
lial phenotype by re-expression of HNF4alpha [28]. These
findings suggest that HNF4alpha should be an important
inducer of the MET in HCC cells, or in some cases, it acts
as an important part of the MET inducers, possibly by
regulating the expression of E-cadherin. Now, combining
with what we have found in the clinical specimens, it
could be speculated that in HCC, MET might also play
an important role in metastatic tumor formation, and
HNF4alpha might just be the important inducer of the
MET, or act as an important part of the MET inducers.Certainly, the exact role of HNF4alpha in the metastatic
tumor formation of HCC is still needed for further con-
firmed, maybe through the model of experimental tumor
metastasis in vivo.
Now, the role of HNF4alpha in the expression regula-
tion of E-cadherin has been further confirmed in our
study. As for the mechanism, recently, it was found that
HNF4alpha could directly inhibit the transcription of
EMT master regulatory genes Snail, Slug and several
mesenchymal markers [13]. We think that it might pos-
sibly be the answer, as zinc finger transcription factors of
the Snail family have been characterized as key repres-
sors of the E-cadherin gene, by acting through inter-
action with specific E-boxes in the proximal promoter
[29]. In our study, it was found that the expression of
HNF4alpha in the primary tumors and their correspon-
ding metastases was significantly positively correlated
with the expression of E-cadherin, and negatively corre-
lated with the expression of Snail and Slug, primarily
demonstrated our conjecture. In addition, it was also
found in previous study that Snail could repress the
transcription of the HNF4alpha gene through a direct
binding to its promoter [30]. So, the regulation relation-
ship between the HNF4alpha and Snail is still needed for
further research.
In our study, it was also found that not all metastases
were detected to express increased E-cadherin, or de-
creased expression of N-cadherin, Fibronectin and
Vimentin. As for this, we consider that it might be that a
second EMT occurred within the metastatic lesions, for
further invasion and disseminations. In the study of Chao
Y, it was found that E-cadherin expression in prostate
cancer metastases was inversely correlated with size of
metastasis, with increased E-cadherin expression in small
metastases compared with large ones [15], suggesting that
the EMT was likely occurring in the metastases.
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tissues both HNF4alpha and E cadherin was high
expressed, while Snail, Slug, Fibronectin, N-cadherin and
Vimentin were mostly low expressed. Compared with
the normal tumor-adjacent tissues, the expression of
HNF4alpha and E cadherin in either primary HCC or their
metastases was mainly reduced, and the expression of Snail,
Slug, Fibronectin and N-cadherin was mainly increased,
suggesting that the reduced expression of HNF4alpha and
E cadherin, and increased expression of Snail, Slug, Fibro-
nectin and N-cadherin may be associated with the occur-
rence or progression of HCC. This confirmed previous
researches [28,31,32]. Recently, the findings in rat liver
cancer model studies suggested that the transcription inhib-
ition of HNF4alpha was related with tumor progression and
dedifferentiation, and exogenous expression of HNF4alpha
could make the chemical-induced rat dedifferentiated
carcinoma reverse its malignant phenotype [33], proving
that reduction of HNF4alpha expression played an import-
ant role in HCC progression, and was closely related with
EMT. Therefore, combining with above results, we could
suppose that the alterations of HNF4alpha expression may
play important roles in occurrence of liver tumors, tumor
progression and metastatic tumor formation. The expres-
sion of HNF4alpha slightly reduced during the occurrence
of HCC, further decreased in HCC progress, while partly
restored during tumor metastases formation.
In the Paget’s seed and soil hypothesis, it was postulated
that cancer cells, or the “seeds”, will only grow in a specific
microenvironment, or “soil” [34]. The reversible pheno-
typic of cancer cells during EMT and MET may therefore
be one way by which cancer cells can adapt to the foreign
soil of ectopic organ microenvironments. To reveal the
mechanisms of the EMT and MET process may help us
interfere this dynamic process, or even further inhibit the
metastasis. Now, our clinical and experimental data
indicate that HNF4alpha might play a crucial role in this
dynamic process during the metastasis of HCC, and the
related mechanism is worth further studying.
Conclusions
In summary, our data indicated that HNF4alpha might
play a crucial role in the process of phenotype transition
during the metastasis of HCC and it may be related with
the process of phenotype transition. Apparently, our study
preliminarily demonstrated the important role of
HNF4alpha, and might provide for further study of related
mechanisms in the metastatic tumor formation of HCC.
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